Powder: -20°C for 3 years | In solvent: -80°C for 1 year
δ-secretase inhibitor 11 is an inhibitor of δ-secretase and can be used as a lead compound for translational development of AD treatment.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 30.00 | |
10 mg | In stock | $ 43.00 | |
25 mg | In stock | $ 97.00 | |
50 mg | In stock | $ 167.00 | |
100 mg | In stock | $ 249.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 39.00 |
Description | δ-secretase inhibitor 11 is an inhibitor of δ-secretase and can be used as a lead compound for translational development of AD treatment. |
In vitro | The inhibitory effect of δ-secretase inhibitor 11 on AEP activity in vitro was tested and the dose-response relationship revealed that the δ-secretase inhibitor 11 had an IC50 value of 0.15 ± 0.09 μM [1]. |
In vivo | It was found that oral administration of δ-secretase inhibitor 11 (10 mg/kg) significantly suppressed brain AEP activity compared to the vehicle treatment. The concentrations of Aβ1–40 and Aβ1–42 in brain lysates of SAMP8 mice were significantly reduced due to AEP inhibition by δ-secretase inhibitor 11. [1] |
Molecular Weight | 220.23 |
Formula | C10H12N4O2 |
CAS No. | 842964-18-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2.2 mg/mL (10 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
δ-secretase inhibitor 11 842964-18-5 Apoptosis Neuroscience Proteases/Proteasome Beta Amyloid Caspase δ-Secretase inhibitor 11 CNS diseases Alzheimer's disease δ secretase inhibitor 11 β-amyloid peptide oxygen-glucose deprivation amyloid precursor protein Abeta asparagine endopeptidase Inhibitor APP AEP Amyloid-β delta-secretase inhibitor 11 Pala cells δsecretase inhibitor 11 inhibit inhibitor